ReviewInternational orthopaedics2006
Pathology of primary malignant bone and cartilage tumours.
Review in International orthopaedics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 101 citations in OpenAlex.
- Primary and radiation induced skull base osteosarcoma: a systematic review of clinical features and treatment outcomes.Journal of neuro-oncology · 2021Pooled it
- Can MRI differentiate between atypical cartilaginous tumors and high-grade chondrosarcoma? A systematic review.Acta orthopaedica · 2020Pooled it
- Treatment strategies for central low-grade chondrosarcoma of long bones: a systematic review of the literature and meta-analysis.Musculoskeletal surgery · 2018Pooled it
- Maxillary chondrosarcoma: a case report.Journal of medical case reports · 2026Article
- Article
- Epidemiology and Chemosensitivity of Primary Malignant Bone Tumors at a Teaching Hospital in South Africa: A 5-Year Retrospective Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2025Article
- Deep learning models in classifying primary bone tumors and bone infections based on radiographs.NPJ precision oncology · 2025Article
- Chondrosarcoma in Proximal Humerus: The First Reported Case in Lebanon and the Middle East of a Female Treated with MUTARS® Shoulder Hemiarthroplasty.Journal of orthopaedic case reports · 2024Article
- Article
- Review
- Delivery of miRNAs Using Nanoparticles for the Treatment of Osteosarcoma.International journal of nanomedicine · 2024Review
- The novel dynamic nomogram and risk classification system constructed for predicting post-surgical overall survival and mortality risk in primary chondrosarcoma: a population study based on SEER database.Journal of cancer research and clinical oncology · 2023Article
- Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation.Cell reports · 2023Article
- Article
- The influence of site on the incidence and diagnosis of solitary central cartilage tumours of the femur. A 21Journal of clinical orthopaedics and trauma · 2022Article
- Impact of tumour stage on the surgical outcomes of scapular chondrosarcoma.International orthopaedics · 2022Article
- Prognostic analysis of telangiectatic osteosarcoma of the extremities.Frontiers in oncology · 2022Article
- Low-grade osteosarcoma is predominant in gnathic osteosarcomas: A report of seven cases of osteosarcoma of the jaw.Clinical and experimental dental research · 2021Article
- Review
- The importance of MRI review following the diagnosis of atypical cartilaginous tumour using image-guided needle biopsy.Skeletal radiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone- and cartilage-forming tumours (osteosarcomas and chondrosarcomas) are rare malignant neoplasms. These tumours are clinically aggressive and often need extensive local and/or systemic treatment. Whereas no other treatment but surgery is currently available for chondrosarcomas, osteosarcomas show an approximately 50-80% response rate to adjuvant chemotherapy. Surgical removal of these tumours is currently mostly performed with limb salvage, but amputation may be required in some cases. In addition, the tumours have a risk of local recurrences adversely affecting the prognosis compared to the primary tumour. In this report we will mainly focus on two of the most prevalent malignant bone tumours, conventional osteosarcoma and conventional chondrosarcoma, and use these to illustrate the problems with the diagnosis of bone sarcomas in general.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.